Signaturefd, LLC Alx Oncology Holdings Inc Transaction History

Signaturefd, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 31, 2024	BUY	$4.81 - $15.38 $96 - $307	20 New	20 $0
Q2 2022 Aug 10, 2022	SELL	$5.89 - $19.46 $765 - $2,529	-130 Closed	0 $0
Q1 2022 May 02, 2022	SELL	$13.65 - $22.06 $491 - $794	-36 Reduced 21.69%	130 $2,000
Q4 2021 Jan 25, 2022	BUY	$21.49 - $74.4 $3,567 - $12,350	166 New	166 $4,000
Q3 2021 Oct 28, 2021	SELL	$52.51 - $80.91 $735 - $1,132	-14 Closed	0 $0
Q2 2021 Jul 26, 2021	BUY	$52.2 - $75.23 $730 - $1,053	14 New	14 $1,000

101

39.7M

134K

17.4K

Ticker ALXO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,747,100
Market Cap $66M
Description
ALX Oncology Holdings Inc., a clinical-stage immuno-oncology company, focuses on developing therapies for patients fighting cancer. Its lead product candidate is ALX148, a CD47 blocking therapeutic that is in Phase 1b/2 clinical trial used for the treatment of myelodysplastic syndromes; and for the treatment of acute myeloid leukemia and non-Hod...

Get notified when there are updates to the investment portfolio of Signaturefd, LLC, based on Form 13F filings with the SEC.

Stay updated on Signaturefd, LLC with notifications on news.